Ignite Creation Date:
2024-07-17 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06482008
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-14
Brief Title:
HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C An Open-label Single-arm Phase II Study
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Organization Data
Organization:
Sun Yat-sen University
Class:
OTHER
Study ID:
B2024-187-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Rong-ping Guo
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-sen University
Old Name:
None
Old Organization:
None